EN

All-in-One Cartridge

Ready to use lyophilized reagent integrates sample prep and qPCR.
Product Information

SARS-CoV-2&Flu A&Flu B

FlashDetect™ LyocartD SARS-CoV-2&Flu A&Flu B Assay

FlashDetect™ LyocartE SARS-CoV-2&Flu A&Flu B Assay


Simultaneous detection of 3 respiratory infections in one cartridge: 

SARS-CoV-2 (ORF1ab, N gene), Influenza A (M gene) and Influenza B (NS1 gene).



Highlights:

  • Results in 20-30 mins

  • LoD as low as 100 copies/mL (SARS-CoV-2)

  • Includes internal control

  • Pre-loaded with lyophilized reagents

  • Contamination-free

  • Room temperature storage and transportation

  • Technical Specification
  • Workflow

Product Name

FlashDetect™ LyocartD SARS-CoV-2&Flu A&Flu B Assay

FlashDetectLyocartE SARS-CoV-2&Flu A&Flu B Assay

Method

Real-Time PCR

All-in-one cartridge integrates sample prep and PCR amplification

AnalytesSARS-CoV-2 (ORF1ab gene, N gene), Influenza A (Flu A), Influenza B (Flu B), Internal Control (RNase P gene)
LoD200 copies/mL(SARS-CoV-2);
500 copies/mL(FluA/FluB)
100 copies/mL(SARS-CoV-2);
500 copies/mL(FluA/FluB)

Clinical 

Sensitivity

SARS-CoV-2: 100.00% (149/149,95% CI: 97.49% to 100.00%)

Flu A: 100.00% (49/49, 95% CI: 92.73% to 100.00%)

Flu B: 100.00% (50/50, 95% CI: 92.86% to 100.00%)

SARS-CoV-2: 100.00% (267/267, 95% CI: 98.63-100.00%)

Flu A: 100.00% ( 170/170, 95% CI: 98.25-100.00%)

Flu B: 100.00% (193/193, 95% CI: 98.46-100.00%)

Clinical 

Specificity

SARS-CoV-2: 99.34% (150/151, 95% CI: 96.34% to 99.88%)

Flu A: 99.60% (250/ 251, 95% CI: 97.78% to 99.93%)

Flu B: 100.00% (250/250, 95% Cl: 98.49% to 100.00%)

SARS-CoV-2: 99.75% (807 /809, 95% CI: 99.11-99.97%)

Flu A: 100.00% (906/906, 95% CI: 99.67-100.00%)
Flu B:  100.00% (883/883, 95% CI:99.66-100.00%)

Detection Time20 mins - 30 mins
Sample TypeNasal, Nasopharyngeal or Oropharyngeal Swabs
Compatible Instrument

FlashDetect™ Nano, Flash10,

Flash20

FlashDetect™ Nano, Flash10
Storage Temperature2-28℃



Product Resources